Arai Toshiyuki, Yamada Hiroko, Namba Tsunehisa, Mori Hiroko, Ishii Hisanari, Yamashita Kouhei, Sasada Masataka, Makino Keisuke, Fukuda Kazuhiko
Department of Anesthesia, Kyoto University Hospital, Kyoto 606-8507, Japan.
Biochem Pharmacol. 2004 Mar 15;67(6):1185-93. doi: 10.1016/j.bcp.2003.11.014.
The intracellular generation of reactive oxygen species (ROS) by 6-formylpterin and its effects on the human T cell functions were examined in vitro. When T cells isolated from fresh blood were incubated with 6-formylpterin for 1hr, the oxygen consumption and concomitant ROS generation were observed. The incubation of T cells with 50-500microM 6-formylpterin for 24hr brought about the elevation of intracellular ROS without inducing cell death. In contrast, the incubation of T cells with exogenously administered hydrogen peroxide (H(2)O(2)) or other pterin derivatives (6-hydroxymethylpterin, pterin-6-carboxylic acid, pterin, neopterin, biopterin and folic acid) for 24hr did not cause the intracellular ROS elevation. In the T cells stimulated with mitogenic lectin phytohemagglutinin (PHA) in conjunction with phorbol myristate acetate (PMA), 6-formylpterin suppressed the NF-kappaB-dependent transcription, the production of cytokines (IFN-gamma and IL-2) and the cell proliferation. These suppressive effects of 6-formylpterin were all reversed by N-acetyl-l-cystein (NAC). However, 6-formylpterin did not inhibit the NF-kappaB-DNA binding of the nuclear extracts obtained from the PHA/PMA-stimulated T cells. Since the NF-kappaB-DNA binding assay performed in vitro merely shows the presence or absence of NF-kappaB subunit in the nuclear extracts but not guarantees the actual binding of NF-kappaB with DNA in the nucleus, these findings suggest that intracellular ROS generated by 6-formylpterin does not affect the translocation of NF-kappaB to the nucleus but that it inhibits the NF-kappaB-dependent transcription in the nucleus, resulting in the suppression of cytokine production and cell proliferation in the activated T cells.
在体外研究了6-甲酰基蝶呤的细胞内活性氧(ROS)生成及其对人T细胞功能的影响。当将从新鲜血液中分离的T细胞与6-甲酰基蝶呤孵育1小时时,观察到耗氧量和伴随的ROS生成。将T细胞与50-500μM的6-甲酰基蝶呤孵育24小时导致细胞内ROS升高而不诱导细胞死亡。相反,将T细胞与外源性过氧化氢(H₂O₂)或其他蝶呤衍生物(6-羟甲基蝶呤、蝶呤-6-羧酸、蝶呤、新蝶呤、生物蝶呤和叶酸)孵育24小时不会导致细胞内ROS升高。在用促有丝分裂凝集素植物血凝素(PHA)联合佛波酯肉豆蔻酸酯(PMA)刺激的T细胞中,6-甲酰基蝶呤抑制NF-κB依赖性转录、细胞因子(IFN-γ和IL-2)的产生以及细胞增殖。6-甲酰基蝶呤的这些抑制作用均被N-乙酰-L-半胱氨酸(NAC)逆转。然而,6-甲酰基蝶呤并不抑制从PHA/PMA刺激的T细胞获得的核提取物的NF-κB-DNA结合。由于体外进行的NF-κB-DNA结合测定仅显示核提取物中NF-κB亚基的存在与否,而不能保证NF-κB在细胞核中与DNA的实际结合,这些发现表明6-甲酰基蝶呤产生的细胞内ROS不影响NF-κB向细胞核的转位,但它抑制细胞核中NF-κB依赖性转录,导致活化T细胞中细胞因子产生和细胞增殖的抑制。